Lava Therapeutics begins dosing in phase 1/2a trial of LAVA-1207 to treat prostate cancer
February 01 2022 - 8:22AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
LAVA Therapeutics NV (NASDAQ:LVTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
LAVA Therapeutics NV (NASDAQ:LVTX)
Historical Stock Chart
From Apr 2023 to Apr 2024